IT1252687B - Vaccino di poxvirus ricombinante del virus del morbillo - Google Patents
Vaccino di poxvirus ricombinante del virus del morbilloInfo
- Publication number
- IT1252687B IT1252687B ITMI913092A ITMI913092A IT1252687B IT 1252687 B IT1252687 B IT 1252687B IT MI913092 A ITMI913092 A IT MI913092A IT MI913092 A ITMI913092 A IT MI913092A IT 1252687 B IT1252687 B IT 1252687B
- Authority
- IT
- Italy
- Prior art keywords
- recombinant poxvirus
- virus
- foreign dna
- morbillo
- vaccine
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 229940024231 poxvirus vaccine Drugs 0.000 title 1
- 241000282472 Canis lupus familiaris Species 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 241000712079 Measles morbillivirus Species 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000178270 Canarypox virus Species 0.000 abstract 1
- 208000000655 Distemper Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000712045 Morbillivirus Species 0.000 abstract 1
- 241000700618 Vaccinia virus Species 0.000 abstract 1
- 208000014058 canine distemper Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62161490A | 1990-11-20 | 1990-11-20 | |
| US77686791A | 1991-10-22 | 1991-10-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI913092A0 ITMI913092A0 (it) | 1991-11-20 |
| ITMI913092A1 ITMI913092A1 (it) | 1993-05-20 |
| IT1252687B true IT1252687B (it) | 1995-06-23 |
Family
ID=27089007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI913092A IT1252687B (it) | 1990-11-20 | 1991-11-20 | Vaccino di poxvirus ricombinante del virus del morbillo |
Country Status (12)
| Country | Link |
|---|---|
| JP (2) | JP3617668B2 (enExample) |
| AU (1) | AU1253892A (enExample) |
| BE (1) | BE1005908A5 (enExample) |
| CA (1) | CA2096633A1 (enExample) |
| CH (1) | CH683921A5 (enExample) |
| DE (2) | DE4192786T1 (enExample) |
| FR (1) | FR2669346B1 (enExample) |
| GB (2) | GB2264949B (enExample) |
| IE (2) | IE68404B1 (enExample) |
| IT (1) | IT1252687B (enExample) |
| NL (2) | NL195058C (enExample) |
| WO (1) | WO1992008789A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5505941A (en) * | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
| US7767449B1 (en) | 1981-12-24 | 2010-08-03 | Health Research Incorporated | Methods using modified vaccinia virus |
| US5833975A (en) * | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
| US6248333B1 (en) | 1990-04-04 | 2001-06-19 | Health Research Inc. | Isolated nucleic acid sequence of equine herpesvirus type 1 glycoprotein D (EHV-1 gD) |
| US5756102A (en) * | 1990-11-20 | 1998-05-26 | Virogenetics Corporation | Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
| JP3602530B2 (ja) * | 1991-03-07 | 2004-12-15 | ヴァイロジェネティクス コーポレイション | 遺伝子操作したワクチン菌株 |
| US5989561A (en) * | 1991-03-07 | 1999-11-23 | Virogenetics Corporation | Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses |
| WO1992016616A1 (en) * | 1991-03-20 | 1992-10-01 | Virogenetics Corporation | Malaria recombinant poxvirus vaccine |
| EP0592546B1 (en) * | 1991-06-14 | 2003-05-28 | Virogenetics Corporation | Immunodeficiency virus recombinant poxvirus vaccine |
| US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
| CN1089370C (zh) * | 1994-12-08 | 2002-08-21 | 中国预防医学科学研究院病毒学研究所 | 表达麻疹病毒l4株血凝素及融合蛋白基因的重组痘苗病毒 |
| AU2118997A (en) * | 1996-02-05 | 1997-08-22 | Johns Hopkins University, The | Measles immunization by dna transcription unit inoculation |
| AU750322B2 (en) | 1997-05-09 | 2002-07-18 | Trustees Of The University Of Pennsylvania, The | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists |
| EP1095948A1 (en) * | 1999-10-28 | 2001-05-02 | Universitätsklinikum Freiburg | Idiotype vaccines |
| AU2002252199B2 (en) * | 2001-03-08 | 2008-01-03 | Emory University | MVA expressing modified HIV envelope, GAG, and POL genes |
| AR052743A1 (es) * | 2006-04-11 | 2007-03-28 | Inst Nac De Tecnologia Agropec | Vector plasmidico de transferencia y virus canarypox recombinante |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2617715B1 (fr) * | 1987-07-07 | 1990-08-31 | Transgene Sa | Vecteur viral et adn recombinant codant pour une ou des proteines de surface (ha et/ou f) d'un morbillivirus, culture cellulaire infectee, proteines obtenues, vaccin et anticorps obtenus |
| DE10399031I1 (de) * | 1987-08-28 | 2004-01-29 | Health Research Inc | Rekombinante Viren. |
| FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
| JPH01218590A (ja) * | 1988-02-29 | 1989-08-31 | Toa Nenryo Kogyo Kk | 組換ワクチニアウイルスを用いたリンダペスト（牛疫）ウイルスワクチン |
-
1991
- 1991-11-13 IE IE396091A patent/IE68404B1/en not_active IP Right Cessation
- 1991-11-13 IE IE960091A patent/IE71643B1/en not_active IP Right Cessation
- 1991-11-19 FR FR9114256A patent/FR2669346B1/fr not_active Expired - Lifetime
- 1991-11-19 BE BE9101066A patent/BE1005908A5/fr not_active IP Right Cessation
- 1991-11-20 DE DE4192786T patent/DE4192786T1/de active Pending
- 1991-11-20 WO PCT/US1991/008703 patent/WO1992008789A1/en not_active Ceased
- 1991-11-20 IT ITMI913092A patent/IT1252687B/it active IP Right Grant
- 1991-11-20 NL NL9120026A patent/NL195058C/nl not_active IP Right Cessation
- 1991-11-20 JP JP50520492A patent/JP3617668B2/ja not_active Expired - Fee Related
- 1991-11-20 GB GB9309414A patent/GB2264949B/en not_active Expired - Lifetime
- 1991-11-20 GB GB9500214A patent/GB2283021B/en not_active Expired - Lifetime
- 1991-11-20 AU AU12538/92A patent/AU1253892A/en not_active Abandoned
- 1991-11-20 CH CH2364/92A patent/CH683921A5/fr not_active IP Right Cessation
- 1991-11-20 CA CA002096633A patent/CA2096633A1/en not_active Abandoned
- 1991-11-20 DE DE4192786A patent/DE4192786B4/de not_active Expired - Lifetime
-
2003
- 2003-07-15 NL NL9900036A patent/NL195095C/nl not_active IP Right Cessation
-
2004
- 2004-06-09 JP JP2004170929A patent/JP3824619B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB2283021B (en) | 1995-07-05 |
| JP3617668B2 (ja) | 2005-02-09 |
| ITMI913092A0 (it) | 1991-11-20 |
| DE4192786T1 (de) | 1994-01-13 |
| AU1253892A (en) | 1992-06-11 |
| NL9120026A (nl) | 1993-09-01 |
| NL195095C (nl) | 2004-01-21 |
| CA2096633A1 (en) | 1992-05-21 |
| JP3824619B2 (ja) | 2006-09-20 |
| IE68404B1 (en) | 1996-06-12 |
| NL195058C (nl) | 2003-07-01 |
| ITMI913092A1 (it) | 1993-05-20 |
| JPH06502996A (ja) | 1994-04-07 |
| IE71643B1 (en) | 1997-02-26 |
| GB2264949A (en) | 1993-09-15 |
| BE1005908A5 (fr) | 1994-03-08 |
| CH683921A5 (fr) | 1994-06-15 |
| NL9900036A (nl) | 2003-10-01 |
| FR2669346B1 (fr) | 1995-07-21 |
| GB2264949B (en) | 1995-07-05 |
| DE4192786B4 (de) | 2006-08-24 |
| FR2669346A1 (fr) | 1992-05-22 |
| GB2283021A (en) | 1995-04-26 |
| GB9500214D0 (en) | 1995-03-01 |
| JP2005040129A (ja) | 2005-02-17 |
| GB9309414D0 (en) | 1993-07-14 |
| WO1992008789A1 (en) | 1992-05-29 |
| IE913960A1 (en) | 1992-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1252687B (it) | Vaccino di poxvirus ricombinante del virus del morbillo | |
| CA2014465A1 (en) | Herpesvirus recombinant poxvirus vaccine | |
| ATE60799T1 (de) | Virus-impfstoff. | |
| ATE105334T1 (de) | Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3. | |
| DK0592546T3 (da) | Immundeficiens-virus rekombinant poxvirus-vaccine | |
| IE802225L (en) | Vaccine stabilizer | |
| ATE117369T1 (de) | Rekombinantes virus der marekschen krankheit und vakzin. | |
| EP0816499A3 (en) | Genomic DNA encoding a polypeptide capable of inducing the production of interferon-gamma | |
| DK0437604T3 (da) | Rekombinant poxvirus- og streptokok M-proteinvaccine | |
| ATE47524T1 (de) | Hundeparvovirus-impfstoffe. | |
| EA200300215A1 (ru) | Вакцинация против вирусов герпеса, ассоциированных с хозяйской клеткой | |
| DE3579617D1 (de) | Lebender gereinigter impfstoff gegen die marek'sche krankheit. | |
| BR9303226A (pt) | Processo e vacina para produzir anticorpos ou imundade mediada por celulas e adenovirus recombinante | |
| GB1486186A (en) | Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection | |
| DE69332264D1 (de) | Mutanten des infektiösen rinder rhinotracheitis-virus und impfstoffe | |
| ATE189702T1 (de) | Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung | |
| BR9403202A (pt) | Método de produção de anticorpos ou imunidade mediada por célula a vírus de imunodeficiência humana, método de proteção contra infecção de vírus de imunodeficiência humana, vacina e adenovírus recombinante | |
| DK0623172T3 (da) | Rekombinant Mareks sygdomsvirus-poxvirusvaccine | |
| ATE160376T1 (de) | Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert | |
| ATE171218T1 (de) | Rekombinanter varicella-zoster-virus-vektor | |
| DE69720024D1 (de) | Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten | |
| DK0491125T3 (da) | Vacciner til equine herpesvira samt deres fremstilling | |
| DE69833568D1 (de) | Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe | |
| DK306379A (da) | Herpesvirusvaccine | |
| EP1074624A4 (en) | GEN 62 OF THE ATTENUATED WINCHPOCK VIRUS STEM OKAUND AND METHOD FOR IDENTIFYING AN ATTENUATED, LIVING WINDPOCK VIRUS STEM USING THIS GENE. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19971125 |